CVSG share price is currently trading at $0.80, up by 2.4% from its previous close of $0.78. The company has a market capitalization of $1.13 billion and an enterprise value of $2.21 billion. The stock is down by over 60% from its 52-week high of $2.06 reached in early March this year.
CVSG share price has been on the rise in recent weeks, as investors have become increasingly bullish on the company’s prospects. The stock is up nearly 20% since early November, and analysts believe there is more upside potential in the months ahead.
The main driver of CVSG’s recent share price increase has been the company’s strong performance in its most recent earnings report.
CVSG reported better-than-expected results for both its top and bottom lines, which led to a number of analysts upgrading their ratings on the stock.
Looking ahead, CVSG is well positioned to continue its momentum. The company is benefiting from favorable industry trends, including continued growth in prescription drug spending and an aging population that will need more healthcare services.
In addition, CVSG’s acquisition of Aetna should provide a significant boost to its business going forward.
Overall, analysts are bullish on CVSG’s outlook and believe that its share price still has room to run higher.
Gama Share Price
Gama Share Price
The GAMA share price is currently trading at $0.50. The company has a market capitalisation of $86.74 million and pays an annual dividend yield of 8.00%.
GAMA is a diversified industrial group with operations in Australia, New Zealand, Asia and the United States. The company’s businesses include manufacturing and distribution of building products, steel fabrication, power generation equipment rental and agricultural machinery sales and service.
In the last 12 months, GAMA’s share price has ranged from $0.43 to $0.60.
At its current price of $0.50, the shares are down 5% from their 52-week high but up 16% from their 52-week low. Analysts have a consensus target price of $0.58 for the shares, which implies upside potential of 16%.
Credit: www.ebay.com
Is Cvsg a Buy?
CVSG is not a buy right now. The company has been underperforming for the past few years, and its stock price has reflected that. CVSG is currently in turnaround mode, and it will take some time for the company to get back on track.
In the meantime, there are better options out there for investors.
Does Cvs Group Pay a Dividend?
CVS does not currently pay a dividend, but has paid dividends in the past. The company has been paying dividends since 1986, but suspended payments in 2008 during the financial crisis. In recent years, CVS has been using its cash flow to repurchase shares and fund other initiatives, such as acquisitions.
While CVS has not declared a dividend in recent years, this could change in the future if the company’s financial situation improves.
CVS Group (CVSG) H1 analyst presentation given 25.3.21
Conclusion
The CVS Group plc (LON:CVSG) share price has fallen by 25% over the past year. However, this could be an opportunity for investors to buy shares in the veterinary services provider at a discount. The company is expected to report strong full-year results on Thursday, which could send the stock higher.
